Loading…

Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir

► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Et...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2010-11, Vol.402 (1), p.163-167
Main Authors: Kumar, Santosh, Earla, Ravinder, Jin, Mengyao, Mitra, Ashim K., Kumar, Anil
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3
cites cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3
container_end_page 167
container_issue 1
container_start_page 163
container_title Biochemical and biophysical research communications
container_volume 402
creator Kumar, Santosh
Earla, Ravinder
Jin, Mengyao
Mitra, Ashim K.
Kumar, Anil
description ► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism. Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest K D (5.9 ± 0.34 mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20 mM) decreased the K D of nelfinavir by >5-fold (0.041 ± 0.007 vs. 0.227 ± 0.038 μM). Similarly, 20 mM ethanol decreased the IC 50 of nelfinavir by >3-fold (2.6 ± 0.5 vs. 8.3 ± 3.1 μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter k cat, it decreased the K m of nelfinavir, suggesting a decrease in catalytic efficiency ( k cat/ K m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.
doi_str_mv 10.1016/j.bbrc.2010.10.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911147467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X10018656</els_id><sourcerecordid>911147467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</originalsourceid><addsrcrecordid>eNp9kEFrGzEQhUVoadykfyCHolsvWVej1e56IZdgkrQQSA4tpCehlUaxzFpyJdkh_z7aOs0xMDDw5r0H8xFyBmwODNrv6_kwRD3n7J8wZyCOyAxYzyoOTHwgM8ZYW_EeHo7J55TWjAGItv9Ejjnr6443_Yxsr6xFnWmwFPNK-TDS4GnaFi2qkQ7OG-cfz6nzKze47II_p8obqnR2e5efp-Dyz319KeiTy6tyK5NdxBzD3k0VJu4eqcfROq-Kcko-WjUm_PK6T8jv66tfyx_V7d3Nz-XlbaXrRZcr7DoY6qFXrWV6aLFZ9MC04SiUacAqo2toGJqaY2OEMMAbo5EjdKYWC2XrE_Lt0LuN4e8OU5YblzSOo_IYdkn2UGB0ou2Kkx-cOoaUIlq5jW6j4rMEJifQci0n0HICPWkFdAl9fa3fDRs0b5H_ZIvh4mDA8uTeYZRJO_QaTYGjszTBvdf_Apa8kDY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911147467</pqid></control><display><type>article</type><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><source>ScienceDirect Freedom Collection</source><creator>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</creator><creatorcontrib>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</creatorcontrib><description>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism. Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest K D (5.9 ± 0.34 mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20 mM) decreased the K D of nelfinavir by &gt;5-fold (0.041 ± 0.007 vs. 0.227 ± 0.038 μM). Similarly, 20 mM ethanol decreased the IC 50 of nelfinavir by &gt;3-fold (2.6 ± 0.5 vs. 8.3 ± 3.1 μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter k cat, it decreased the K m of nelfinavir, suggesting a decrease in catalytic efficiency ( k cat/ K m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2010.10.014</identifier><identifier>PMID: 20937259</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alcohol ; Alcoholism ; Alcoholism - complications ; Alcoholism - enzymology ; Anti-Retroviral Agents - pharmacokinetics ; Anti-Retroviral Agents - pharmacology ; Binding Sites - drug effects ; CYP3A4 ; Cytochrome P-450 CYP3A - chemistry ; Cytochrome P-450 CYP3A - metabolism ; Cytochrome P-450 CYP3A Inhibitors ; Ethanol - metabolism ; Ethanol - pharmacology ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - enzymology ; Human immunodeficiency virus ; Humans ; Inactivation, Metabolic ; Inhibition ; Liver - enzymology ; Metabolism ; Nelfinavir ; Nelfinavir - pharmacokinetics ; Nelfinavir - pharmacology ; Protein Binding - drug effects ; Spectral binding</subject><ispartof>Biochemical and biophysical research communications, 2010-11, Vol.402 (1), p.163-167</ispartof><rights>2010</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</citedby><cites>FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20937259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Santosh</creatorcontrib><creatorcontrib>Earla, Ravinder</creatorcontrib><creatorcontrib>Jin, Mengyao</creatorcontrib><creatorcontrib>Mitra, Ashim K.</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism. Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest K D (5.9 ± 0.34 mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20 mM) decreased the K D of nelfinavir by &gt;5-fold (0.041 ± 0.007 vs. 0.227 ± 0.038 μM). Similarly, 20 mM ethanol decreased the IC 50 of nelfinavir by &gt;3-fold (2.6 ± 0.5 vs. 8.3 ± 3.1 μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter k cat, it decreased the K m of nelfinavir, suggesting a decrease in catalytic efficiency ( k cat/ K m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</description><subject>Alcohol</subject><subject>Alcoholism</subject><subject>Alcoholism - complications</subject><subject>Alcoholism - enzymology</subject><subject>Anti-Retroviral Agents - pharmacokinetics</subject><subject>Anti-Retroviral Agents - pharmacology</subject><subject>Binding Sites - drug effects</subject><subject>CYP3A4</subject><subject>Cytochrome P-450 CYP3A - chemistry</subject><subject>Cytochrome P-450 CYP3A - metabolism</subject><subject>Cytochrome P-450 CYP3A Inhibitors</subject><subject>Ethanol - metabolism</subject><subject>Ethanol - pharmacology</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - enzymology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Inactivation, Metabolic</subject><subject>Inhibition</subject><subject>Liver - enzymology</subject><subject>Metabolism</subject><subject>Nelfinavir</subject><subject>Nelfinavir - pharmacokinetics</subject><subject>Nelfinavir - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Spectral binding</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kEFrGzEQhUVoadykfyCHolsvWVej1e56IZdgkrQQSA4tpCehlUaxzFpyJdkh_z7aOs0xMDDw5r0H8xFyBmwODNrv6_kwRD3n7J8wZyCOyAxYzyoOTHwgM8ZYW_EeHo7J55TWjAGItv9Ejjnr6443_Yxsr6xFnWmwFPNK-TDS4GnaFi2qkQ7OG-cfz6nzKze47II_p8obqnR2e5efp-Dyz319KeiTy6tyK5NdxBzD3k0VJu4eqcfROq-Kcko-WjUm_PK6T8jv66tfyx_V7d3Nz-XlbaXrRZcr7DoY6qFXrWV6aLFZ9MC04SiUacAqo2toGJqaY2OEMMAbo5EjdKYWC2XrE_Lt0LuN4e8OU5YblzSOo_IYdkn2UGB0ou2Kkx-cOoaUIlq5jW6j4rMEJifQci0n0HICPWkFdAl9fa3fDRs0b5H_ZIvh4mDA8uTeYZRJO_QaTYGjszTBvdf_Apa8kDY</recordid><startdate>20101105</startdate><enddate>20101105</enddate><creator>Kumar, Santosh</creator><creator>Earla, Ravinder</creator><creator>Jin, Mengyao</creator><creator>Mitra, Ashim K.</creator><creator>Kumar, Anil</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20101105</creationdate><title>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</title><author>Kumar, Santosh ; Earla, Ravinder ; Jin, Mengyao ; Mitra, Ashim K. ; Kumar, Anil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alcohol</topic><topic>Alcoholism</topic><topic>Alcoholism - complications</topic><topic>Alcoholism - enzymology</topic><topic>Anti-Retroviral Agents - pharmacokinetics</topic><topic>Anti-Retroviral Agents - pharmacology</topic><topic>Binding Sites - drug effects</topic><topic>CYP3A4</topic><topic>Cytochrome P-450 CYP3A - chemistry</topic><topic>Cytochrome P-450 CYP3A - metabolism</topic><topic>Cytochrome P-450 CYP3A Inhibitors</topic><topic>Ethanol - metabolism</topic><topic>Ethanol - pharmacology</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - enzymology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Inactivation, Metabolic</topic><topic>Inhibition</topic><topic>Liver - enzymology</topic><topic>Metabolism</topic><topic>Nelfinavir</topic><topic>Nelfinavir - pharmacokinetics</topic><topic>Nelfinavir - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Spectral binding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Santosh</creatorcontrib><creatorcontrib>Earla, Ravinder</creatorcontrib><creatorcontrib>Jin, Mengyao</creatorcontrib><creatorcontrib>Mitra, Ashim K.</creatorcontrib><creatorcontrib>Kumar, Anil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Santosh</au><au>Earla, Ravinder</au><au>Jin, Mengyao</au><au>Mitra, Ashim K.</au><au>Kumar, Anil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2010-11-05</date><risdate>2010</risdate><volume>402</volume><issue>1</issue><spage>163</spage><epage>167</epage><pages>163-167</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>► Methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol exhibit type I spectra with CYP3A4, and ethanol shows the highest binding affinity for CYP3A4. ► Ethanol increases the spectral binding affinity of nelfinavir to CYP3A4. ► Ethanol increases the inhibition of CYP3A4 by nelfinavir. ► Ethanol decreases the catalytic efficiency of nelfinavir metabolism. Cytochrome P450 3A4 (CYP3A4) is the most abundant CYP enzyme in the liver and metabolizes approximately 50% of the drugs, including antiretrovirals. Although CYP3A4 induction by ethanol and impact of CYP3A4 on drug metabolism and toxicity is known, CYP3A4-ethanol physical interaction and its impact on drug binding, inhibition, or metabolism is not known. Therefore, we studied the effect of ethanol on binding and inhibition of CYP3A4 with a representative protease inhibitor, nelfinavir, followed by the effect of alcohol on nelfinavir metabolism. Our initial results showed that methanol, ethanol, isopropanol, isobutanol, and isoamyl alcohol bind in the active site of CYP3A4 and exhibit type I spectra. Among these alcohol compounds, ethanol showed the lowest K D (5.9 ± 0.34 mM), suggesting its strong binding affinity with CYP3A4. Ethanol (20 mM) decreased the K D of nelfinavir by &gt;5-fold (0.041 ± 0.007 vs. 0.227 ± 0.038 μM). Similarly, 20 mM ethanol decreased the IC 50 of nelfinavir by &gt;3-fold (2.6 ± 0.5 vs. 8.3 ± 3.1 μM). These results suggest that ethanol facilitates binding of nelfinavir with CYP3A4. Furthermore, we performed nelfinavir metabolism using LCMS. Although ethanol did not alter k cat, it decreased the K m of nelfinavir, suggesting a decrease in catalytic efficiency ( k cat/ K m). This is an important finding because alcoholism is prevalent in HIV-1-infected persons and alcohol is shown to decrease the response to antiretroviral therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20937259</pmid><doi>10.1016/j.bbrc.2010.10.014</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2010-11, Vol.402 (1), p.163-167
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_911147467
source ScienceDirect Freedom Collection
subjects Alcohol
Alcoholism
Alcoholism - complications
Alcoholism - enzymology
Anti-Retroviral Agents - pharmacokinetics
Anti-Retroviral Agents - pharmacology
Binding Sites - drug effects
CYP3A4
Cytochrome P-450 CYP3A - chemistry
Cytochrome P-450 CYP3A - metabolism
Cytochrome P-450 CYP3A Inhibitors
Ethanol - metabolism
Ethanol - pharmacology
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - enzymology
Human immunodeficiency virus
Humans
Inactivation, Metabolic
Inhibition
Liver - enzymology
Metabolism
Nelfinavir
Nelfinavir - pharmacokinetics
Nelfinavir - pharmacology
Protein Binding - drug effects
Spectral binding
title Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T18%3A03%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20ethanol%20on%20spectral%20binding,%20inhibition,%20and%20activity%20of%20CYP3A4%20with%20an%20antiretroviral%20drug%20nelfinavir&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Kumar,%20Santosh&rft.date=2010-11-05&rft.volume=402&rft.issue=1&rft.spage=163&rft.epage=167&rft.pages=163-167&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2010.10.014&rft_dat=%3Cproquest_cross%3E911147467%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-e771b3b9a6f0cb6e58910cd2e4ad51fadc3150ed32e5d44d125dce2e17d348af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=911147467&rft_id=info:pmid/20937259&rfr_iscdi=true